Deo Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2004.
2004 Chennai, Tamil Nadu, India Active
Last Updated:
Access Report
About Deo Pharmaceuticals Private Limited

Deo Pharmaceuticals Private Limited, a active private limited company, was established on 06 December 2004 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231TN2004PTC054831. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.74 M.

It upholds a compliant status. Its leadership includes Somasekharan Sureshbabu (Director), Ramalingaiyar Sadhanantham (Director), Jayanthi (Alternate Director). Past directors included Perumal Pillai Somasekharan, Ramalingaiyar Sadhanantham. It holds ₹1.17 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at No.60/61,Krishna Industrial Estate, Vanagaram Mettukuppam, Chennai, Tamil Nadu, 600095.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231TN2004PTC054831

  • Registration Number

    054831

  • Incorporation Date

    06 December 2004

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.74 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.74 M
  • Company Age 21 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 1.17 Cr
  • Revenue Growth **** 43.84%
  • Profit Growth **** -32.87%
  • Ebitda **** -38.79%
  • Net Worth -12.11%
  • Total Assets -11.38%
Company report

Deo Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Deo Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Deo Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Somasekharan Sureshbabu Director 06 Dec 2004 Current
Ramalingaiyar Sadhanantham Director 12 Jan 2007 Current
Jayanthi Alternate Director 06 May 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 31 Mar 2020 Past
Pramod Abcsdd Additional Director 29 Sep 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Deo Pharmaceuticals.

Deo Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 43.84% increase. The company also saw a substantial fall in profitability, with a 32.87% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.11%.

Deo Pharmaceuticals revenue growth over time
Deo Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 43.84%
*******
*******
*******
*******
Revenue from Operations
*******
 46.23%
*******
*******
*******
*******
Total Assets
*******
 -11.38%
*******
*******
*******
*******
Profit or Loss
*******
 -32.87%
*******
*******
*******
*******
Net Worth
*******
 -12.11%
*******
*******
*******
*******
EBITDA
*******
 -38.79%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Deo Pharmaceuticals?

Unlock access to Deo Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹11,680,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • State Bank Of Travancore : 0.68 Cr
  • State Bank Of India : 0.49 Cr
Latest Charge Details
Date Lender Amount Status
21 Nov 2019 State Bank Of India ₹4.90 M Open
23 Mar 2010 State Bank Of Travancore ₹0.72 M Open
08 Aug 2007 State Bank Of Travancore ₹0.61 M Open
02 Jun 2007 State Bank Of Travancore ₹4.70 M Open
26 May 2007 State Bank Of Travancore ₹0.75 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Deo Pharmaceuticals?

Unlock and access historical data on people associated with Deo Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Deo Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Deo Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Deo Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Deo Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Director Appointment

    The activity Jayanthi was appointed as a Alternate Director was appointed as a Alternate Director on 06 May 2025 & has been associated with this company since 10 months 13 days . was completed.

  • Balance Sheet

    The activity Deo Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was completed.

  • Charges

    Progress on A charge with State Bank Of India amounted to Rs. 4.90 M with Charge ID 100306349 was registered on 21 Nov 2019. was documented.

  • Charges

    The activity A charge with State Bank Of Travancore of Rs. 4.70 M registered on 02 Jun 2007 with Charge ID 10073752 was modified on 23 Mar 2015. was completed.

  • Charges

    A charge with State Bank Of Travancore amounted to Rs. 0.72 M with Charge ID 10214694 was registered on 23 Mar 2010. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Deo Pharmaceuticals Private Limited?

The CIN of Deo Pharmaceuticals Private Limited is U24231TN2004PTC054831.

Where is Deo Pharmaceuticals Private Limited headquartered?

Deo Pharmaceuticals Private Limited is headquartered at No.60/61,Krishna Industrial Estate, Vanagaram Mettukuppam, Chennai, Tamil Nadu, 600095.

When was Deo Pharmaceuticals Private Limited incorporated?

Deo Pharmaceuticals Private Limited was incorporated on 06 December 2004.

Who are the current directors of Deo Pharmaceuticals Private Limited?

The current directors of Deo Pharmaceuticals Private Limited are

What is the primary industry of Deo Pharmaceuticals Private Limited?

The primary industry of Deo Pharmaceuticals Private Limited is Manufacturing.

Is Deo Pharmaceuticals Private Limited a listed company?

Deo Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Deo Pharmaceuticals Private Limited?

The authorized capital of Deo Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.74 M.

What is the compliance status of Deo Pharmaceuticals Private Limited?

The compliance status of Deo Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available